Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Late-Stage Pipeline

50%

7 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

6 recruiting1 with results

Enrollment reporting

Analytics

Phase 4

4(28.6%)

Phase 3

3(21.4%)

Phase 1/2

3(21.4%)

Phase 2

3(21.4%)

Phase 1

1(7.1%)

14Total

Phase 4(4)

Phase 3(3)

Phase 1/2(3)

Phase 2(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT06560801Phase 4Recruiting

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

Role: lead

NCT06244758Phase 3Completed

Finerenone and Renal Oxidative Stress

Role: lead

NCT04225390Phase 2Completed

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy

Role: lead

NCT04610476Phase 3Unknown

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Role: lead

SYF1ac00c471fe4433a9c45c0a5f827a934Phase 2Not Yet Recruiting

Multi-center, single-arm, phase II clinical trial evaluating efficacy and in-vivo homing of adoptively transferred autologous ex-vivo expanded regulatory T cells in adults with ulcerative colitis

Role: lead

SYF20d2a4747c4749108c558d8c422a178fPhase 2Unknown

Inhibition of JAK enzymes in early stage joint inflammation

Role: lead

SYF80e5a5e6f9304b26a3a967ea53dfe07dPhase 4Unknown

U3P study - Upadacitinib in Psoriatic Arthritis Pain Processing

Role: lead

SYF93464794e0624aee94762a64510a7c54Phase 3Recruiting

Maternal oxygen therapy during pregnancy for unborn babies with underdeveloped structures on the left side of the heart

Role: lead

SYFa0d5cc11c3d247318fc321057aebfebdPhase 1/2Recruiting

A phase I/II study of CAR-expressing Allogenic iPSC derived NK cells for treatment of autoiMmune disease by B cELl depletion - CARAMEL

Role: lead

SYFa2e48ad09a294b5985750805e17c6e8fPhase 4Unknown

Rapid pain control in Ixekizumab targeted axial spondyloarthritis

Role: lead

SYFa58b345fcf0544c18e39cd585961f605Phase 1/2Not Yet Recruiting

A Long-Term Follow-Up Study to Assess the Safety and Efficacy of B-Cell-Directed Therapy in Patients with Systemic Autoimmune Disease (B-CARE)

Role: lead

SYFb93471c80668497a904c1552f0cf853dPhase 1Recruiting

A multiCenter phase I study of aUtologous CD19 CAR T cElls for therapy refractory chronic GvHD (CURE-cGvHD)

Role: lead

SYFc815cff2976d435faecdf0dbfc17ee71Phase 4Recruiting

Prospective, multicentre, open-label clinical trial on the effect of GUSelkumab on the resolution of ultrasound-proven ENThEsitis in patients with pSoriatic arthriTis

Role: lead

SYFd2c362a43b7c4d6dae5f1ca07a420dfdPhase 1/2Recruiting

A phase I/II study of CAR-T cells in AutoiMmune disease resistant to B cell Abrogation - CARAMBA

Role: lead

All 14 trials loaded